Otaplimastat (Standard)
Otaplimastat (Standard) is the analytical standard of Otaplimastat (HY-109097). This product is intended for research and analytical applications. Otaplimastat (SP-8203), a matrix metalloproteinase (MMP) inhibitor, blocks N-methyl-D-aspartate (NMDA) receptor-mediated excitotoxicity in a competitive manner. Otaplimastat also exhibits anti-oxidant activity. Otaplimastat can be used for the research of brain ischemic injury.
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 1176758-04-5
- Fòrmula: C28H34N6O5
- Peso molecular:534.61
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Product Information
-
Chemical Information
- Pureza y Documentación
-
Help & FAQs
-
HY-109097
OtaplimastatMMP Inhibitor -
HY-12169
MarimastatMMP Inhibitor -
HY-148905
p-Aminophenylmercuric acetateMatrix Metalloproteinases Activator -
HY-13564
BatimastatMMP Inhibitor -
HY-118694
TAPI-0TACE/MMP Inhibitor -
HY-10293
AderbasibADAM10/17 Inhibitor -
HY-146754
MMP2-IN-1MMP2 Inhibitor -
HY-12170A
Prinomastat hydrochlorideMMP Inhibitor -
HY-120793
CMC2.24Ras/MMPs Inhibitor -
HY-B0099S
Edaravone-d5Stable Isotope -
HY-N10176
D-IsofloridosideROS/MMP Inhibitor -
HY-13564R
Batimastat (Standard)MMP Inhibitor
Product Information
Information
Aplicación
The compound is the grade of analytical standard, which is the reference standard supplied assay. It is commonly used in qualitative, quantitative and methodological research experiments in HPLC, GC and MS.
Chemical Information
-
No. CAS 1176758-04-5
-
Peso molecular 534.61
-
Fòrmula C28H34N6O5
-
SMILES
CC(N(CCCN1C(NC2=C(C=CC=C2)C1=O)=O)CCCCNCCCN3C(NC4=C(C=CC=C4)C3=O)=O)=O
-
Synonyms
SP-8203 (Standard)
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
[1]. Noh SJ, et, al. SP-8203 shows neuroprotective effects and improves cognitive impairment in ischemic brain injury through NMDA receptor. Pharmacol Biochem Behav. 2011 Nov;100(1):73-80. [Content Brief]
[2]. Noh SJ, et, al. SP-8203 reduces oxidative stress via SOD activity and behavioral deficit in cerebral ischemia. Pharmacol Biochem Behav. 2011 Mar;98(1):150-4. [Content Brief]
[3]. Kim JS, et, al. Safety and Efficacy of Otaplimastat in Patients with Acute Ischemic Stroke Requiring tPA (SAFE-TPA): A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Study. Ann Neurol. 2020 Feb;87(2):233-245. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Otaplimastat (Standard) Related Classifications
HY-109097R Related Classifications
Powered by Bioz